IMI launches new website

A new interactive, state-of-the-art website to mobilise participation in the Innovative Medicines Initiative (IMI) across Europe has been launched by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA), with the URL of www.imi-europe.org.

The IMI is a pan-European public and private sector collaboration between patient organisations, universities, hospitals, regulatory authorities as well as small and large biopharmaceutical companies. The objective of IMI is to support the faster discovery and development of better medicines.

The website is designed to enhance communication and information flow between everyone involved in biomedical research across Europe. The new website enables patients, all researchers and regulators to learn more about the progress of IMI, its events and organisation. These groups of stakeholders will also be able to ask questions about IMI directly, giving them a voice in shaping future biomedical research in Europe.

Octavi Quintana Trias of the European Commission said: 'The Innovative Medicines Initiative is key to developing a dynamic and innovative knowledge based economy in Europe and this excellent website moves us forward towards this goal. The Commission is looking forward to starting the implementation of the Innovative Medicines Initiative together with EFPIA and the Member States as soon as possible.'

'This website is an excellent communication resource for scientists and patients who are planning to participate in the Innovative Medicines Initiative,' added Jonathan Knowles, chair of the research directors' group at EFPIA.